Grants per year
Personal profile
Research Interests
General surgical pathology, Pulmonary pathology
Certifications and Licenses
| Anatomic Pathology | |
| Anatomic Pathology & Clinical Pathology |
Training Experience
| 1990 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, Medicine, Gandhi Medical College
… → 1982
Research interests keywords
- Pathology
Fingerprint
Dive into the research topics where Anjana V Yeldandi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Core A: Administration
Sznajder, J. I., Kwasny, M. J., Rademaker, A. W. & Yeldandi, A. V.
National Heart, Lung, and Blood Institute
4/1/09 → 4/30/15
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. & Yeldandi, A. V.
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I., Budinger, G. S., Chandel, N., Glucksberg, M. R., Goldman, R., Kamp, D. W., Ridge, K. M., Sporn, P. H. & Yeldandi, A. V.
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. & Yeldandi, A. V.
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I., Budinger, G. S., Chandel, N., Glucksberg, M. R., Goldman, R., Kamp, D. W., Ridge, K. M., Sporn, P. H. & Yeldandi, A. V.
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs (Nature Communications, (2022), 13, 1, (6358), 10.1038/s41467-022-33767-y)
Wang, W., Bale, S., Wei, J., Yalavarthi, B., Bhattacharyya, D., Yan, J. J., Abdala-Valencia, H., Xu, D., Sun, H., Goncalves Marangoni, R., Herzog, E., Berdnikovs, S., Miller, S. D., Sawalha, A. H., Tsou, P. S., Awaji, K., Yamashita, T., Sato, S., Asano, Y., Tiruppathi, C., & 4 others, Dec 2023, In: Nature communications. 14, 1, 523.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Multimodal imaging of an acute presentation of ocular histoplasmosis syndrome in an immunocompetent patient
Janetos, T. M., Goldstein, D. A., Yeldandi, A. V., Kurup, S. P. & Bhat, P., Dec 2023, In: American Journal of Ophthalmology Case Reports. 32, 101896.Research output: Contribution to journal › Article › peer-review
Open Access -
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
Hassler, L., Wysocki, J., Gelarden, I., Sharma, I., Tomatsidou, A., Ye, M., Gula, H., Nicoleascu, V., Randall, G., Pshenychnyi, S., Khurram, N., Kanwar, Y., Missiakas, D., Henkin, J., Yeldandi, A. & Batlle, D., Jul 2022, In: Journal of the American Society of Nephrology. 33, 7Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Clinical Characteristics and Outcomes of Patients with COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant
Kurihara, C., Manerikar, A., Querrey, M., Felicelli, C., Yeldandi, A., Garza-Castillon, R., Lung, K., Kim, S., Ho, B., Tomic, R., Arunachalam, A., Budinger, G. R. S., Pesce, L. & Bharat, A., Feb 15 2022, In: JAMA. 327, 7, p. 652-661 10 p.Research output: Contribution to journal › Article › peer-review
Open Access58 Scopus citations -
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
Wang, W., Bale, S., Wei, J., Yalavarthi, B., Bhattacharyya, D., Yan, J. J., Abdala-Valencia, H., Xu, D., Sun, H., Goncalves Marangoni, R., Herzog, E., Berdnikovs, S., Miller, S. D., Sawalha, A. H., Tsou, P. S., Awaji, K., Yamashita, T., Sato, S., Asano, Y., Tiruppathi, C., & 4 others, Dec 2022, In: Nature communications. 13, 1, 6358.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Datasets
-
Suppl_Fig._2 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Contributor), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. V. (Creator), Wei, J. (Creator), Varga, J. (Creator), Wenxia, W. (Contributor) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.9375524, https://sage.figshare.com/articles/Suppl_Fig_2_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375524
Dataset
-
Suppl_Fig._1 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Contributor), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. V. (Creator), Wei, J. (Creator), Varga, J. (Creator), Wenxia, W. (Contributor) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.9375521, https://sage.figshare.com/articles/Suppl_Fig_1_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375521
Dataset
-
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Contributor), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. V. (Creator), Wei, J. (Creator) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4611566, https://sage.figshare.com/collections/The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/4611566
Dataset
-
Suppl_Fig._3 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Contributor), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. V. (Creator), Wei, J. (Creator), Varga, J. (Creator), Wenxia, W. (Contributor) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.9375530, https://sage.figshare.com/articles/Suppl_Fig_3_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375530
Dataset